Tc99mDMSAIIIRadiochemicalPurityChecker

Tc-99m DMSA(III) Radiochemical Purity Checker

api RPH Tc-99m renal imaging nuclear medicine CSV→JSON URS & FS rule-based
Open selection

Utility description: Tc-99m DMSA(III) Radiochemical Purity Checker

Tc-99m DMSA(III) Radiochemical Purity Checker — Technetium-99m DMSA(III) for renal scintigraphy

ℹ️  Utility checks critical parameters of Tc-99m DMSA(III):
    • Radiochemical purity (≥90-95%)
    • Free pertechnetate (≤5%)
    • Reduced/hydrolyzed technetium (≤5%)
    • Aluminum oxide (<5 ppm)
    • pH (4.0-7.0)
    • Endotoxins (<175 EU/mL)
    • Sterility, heavy metals, stability time (≤4 hours)

⚠️  CRITICAL: Low RCP <90% → accumulation in thyroid gland and stomach!
    Free pertechnetate >5% → false imaging results!
    Stability time exceedance >4h → complex degradation and reduced efficacy!

Usage:
  Tc99mDMSAIIIRadiochemicalPurityChecker.exe                            → demo mode (console output)
  Tc99mDMSAIIIRadiochemicalPurityChecker.exe input.csv output.json      → evaluate your data

Input format:
BatchNumber,RadiochemicalPurityPercent,FreePertechnetatePercent,ReducedHydrolyzedTechnetiumPercent,AluminumOxidePPM,pH,EndotoxinsEU_per_mL,SterilityTest,HeavyMetalsPPM,HoursSincePreparation

Example (sterility: 0=sterile, 1=contaminated):
  TC99M-DMSA-2026-001,97.5,1.2,1.3,2.5,5.5,50.0,0,3.0,2.0

— WHY IS THIS NEEDED?
Technetium-99m DMSA(III) — widely used radiopharmaceutical for renal cortical visualization:
• 6.02-hour half-life — optimal for diagnostics
• 140 keV gamma radiation — ideal for gamma cameras
• High affinity for renal cortex (cortical visualization)
• Clinically proven efficacy in kidney function assessment, scarring, pyelonephritis

⚠️  CRITICAL:
• Radiochemical purity ≥90-95% — ensures specific accumulation in kidneys
• Free pertechnetate ≤5% — free Tc-99m accumulates in thyroid, stomach, and salivary glands, creating artifacts
• Reduced/hydrolyzed technetium ≤5% — colloidal technetium is taken up by reticuloendothelial system (liver, spleen)
• Aluminum oxide <5 ppm — excess Al³⁺ disrupts complexation and reduces RCP to 99.5-99.69%
• pH 4.0-7.0 — critical for DMSA complex stability and prevention of dissociation
• Endotoxins <175 EU/mL — critical for IV administration!
• Sterility — MANDATORY for all parenteral forms!
• Usage time ≤4 hours — complex is unstable, oxidation and dissociation occur

Key features:
• Radiochemical purity check (main quality parameter)
• Control of two main impurities: free pertechnetate and reduced technetium
• Aluminum oxide monitoring as critical labeling quality factor
• pH control for complex stability assurance
• Time since preparation check (critical for short-lived isotopes)
• Comprehensive microbiological safety assessment

Critical parameters:
• Radiochemical purity: ≥90.0% (optimal ≥95%)
• Free pertechnetate: ≤5.0%
• Reduced/hydrolyzed technetium: ≤5.0%
• Aluminum oxide: <5.0 ppm
• pH: 4.0–7.0
• Endotoxins: <175 EU/mL
• Sterility: no microbial growth
• Heavy metals: ≤10 ppm
• Stability time: ≤4 hours

💡 Usage tips:
1. Radiochemical purity controlled by TLC or HPLC with radio-detector
2. Free pertechnetate determined on silica gel strips (mobile phase: acetone)
3. Colloidal technetium determined on paper (mobile phase: saline)
4. Aluminum controlled by colorimetric method or ICP-MS
5. All measurements should be performed within 4 hours after synthesis
6. If RCP <90% — batch rejected (critical parameter for clinical use)!

⚠️ Note: Tc-99m DMSA(III) is one of the most important diagnostic radiopharmaceuticals for nephrology. Low radiochemical purity leads to false-positive results (accumulation in thyroid, stomach) and reduced diagnostic value. Quality control must be performed before each use.

input.csv

BatchNumber,RadiochemicalPurityPercent,FreePertechnetatePercent,ReducedHydrolyzedTechnetiumPercent,AluminumOxidePPM,pH,EndotoxinsEU_per_mL,SterilityTest,HeavyMetalsPPM,HoursSincePreparation
TC99M-DMSA-2026-001,97.5,1.2,1.3,2.5,5.5,50.0,0,3.0,2.0
TC99M-DMSA-2026-002,92.0,3.5,4.2,4.8,6.2,120.0,0,8.0,3.5
TC99M-DMSA-2026-003,88.0,6.5,5.8,6.2,7.5,200.0,1,12.0,5.0

URS & FS — user requirements and functional specification

URS — User Requirements Specification

  • The utility shall accept input.csv with the headers defined by the data contract.
  • Before calculation, the utility shall detect missing fields, type errors and invalid values.
  • The utility shall deterministically perform “Tc-99m DMSA(III) Radiochemical Purity Checker”.
  • The checks shall include the following criteria: Radiochemical purity: ≥90.0% (optimal ≥95%); Free pertechnetate: ≤5.0%; Reduced/hydrolyzed technetium: ≤5.0%; Aluminum oxide: <5.0 ppm; pH: 4.0–7.0; Endotoxins: <175 EU/mL; Sterility: no microbial growth; Heavy metals: ≤10 ppm; Stability time: ≤4 hours.
  • Each processed record shall receive a clear PASS, WARNING or FAIL status with the reason.
  • The result shall be written to output.json and retain the source values used for the checks.
  • The result supports batch-data review; release remains with authorised QA/QC personnel.

FS — Functional Specification

  1. Run Tc99mDMSAIIIRadiochemicalPurityChecker.exe in demo mode or with input.csv output.json arguments.
  2. Read UTF-8 CSV and validate the header and mandatory columns.
  3. Convert values to the expected types and validate admissibility.
  4. Perform the calculation or rule checks for “Tc-99m DMSA(III) Radiochemical Purity Checker”.
  5. Create individual check results and the overall status.
  6. Write machine-readable JSON; invalid input shall not appear as a successful result.

input.csv example

BatchNumber,RadiochemicalPurityPercent,FreePertechnetatePercent,ReducedHydrolyzedTechnetiumPercent,AluminumOxidePPM,pH,EndotoxinsEU_per_mL,SterilityTest,HeavyMetalsPPM,HoursSincePreparation
TC99M-DMSA-2026-001,97.5,1.2,1.3,2.5,5.5,50.0,0,3.0,2.0

Minimum output.json structure

{
  "utility": "Tc99mDMSAIIIRadiochemicalPurityChecker",
  "source": "input.csv",
  "status": "PASS|WARNING|FAIL",
  "checks": [
    {
      "parameter": "example",
      "status": "PASS",
      "message": "criterion satisfied"
    }
  ],
  "errors": []
}

Before operational use

  • Limits and coefficients shall be approved before operational use.
  • After an executable or rule change, repeat the affected tests.
  • Retain the source CSV and JSON result together in the controlled process.

Included in packages

Radiopharmaceutical Diagnostics and Therapy QC Suite

36 utilities for clinically oriented radiopharmaceutical and workflow quality control: PET/SPECT tracers, the Tc-99m renal workflow, PRRT, PSMA therapy, targeted alpha therapy, radioembolization, bone-pain palliation, immuno-PET and generator-based radionuclide control.

Open

RPH isotope family: Tc-99m

Tc-99m radiopharmaceuticals, kit preparation, generator control, SPECT workflows and calculation utilities.

Open

RPH organ/system: endocrine, thyroid and NET

Radioiodine, thyroid/parathyroid, somatostatin receptor, MIBG and neuroendocrine workflows.

Open

RPH organ/system: hepatobiliary and GI

HIDA, mebrofenin, gallbladder, gastric emptying, GI transit, bleeding and liver/spleen imaging.

Open

RPH organ/system: renal and urinary

Renography, GFR/ERPF, renal uptake, DMSA/MAG3/DTPA and bladder-related workflows.

Open

RPH Tc-99m Renal Radiopharmaceutical and Imaging QC Suite

16 utilities covering the Tc-99m renal workflow: generator eluate and Mo-99 breakthrough, Sn(II), labeling stoichiometry and pH, radiochemical purity and stability of MAG3, DTPA, DMSA(III) and glucoheptonate, gamma-camera uniformity, renal uptake and plasma clearance, bladder voiding efficiency, patient dosimetry and decay-in-storage waste management.

Open

RPH use case: Tc-99m renal and nephrourology

Renal radiopharmaceuticals and calculation workflows: MAG3, DTPA, DMSA, glucoheptonate, generator Tc-99m, dynamic renography, GFR/ERPF and dosimetry.

Open

RPH workflow: imaging QC and quantitative interpretation

Acquisition, uptake, clearance, perfusion, transit, ejection fraction, segmentation and quantitative imaging.

Open

RPH workflow: instruments, devices and radiation safety

PET/gamma-camera state, calibration, detector QC, energy window, TOF, shielding and radiation safety.

Open

RPH workflow: product release QC

Assay, purity, sterility, endotoxins, pH, impurities, appearance and batch-release checks.

Open

RPH workflow: stability, storage, decay and waste

Kinetic stability, shelf life, decay correction, expiry, storage, trend and radioactive waste.

Open

RPH workflow: synthesis, labelling and kit reconstitution

Radiolabelling, synthesis, chelation, reducing agent, pH/stoichiometry and kit preparation.

Open